Literature DB >> 2480664

Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder.

A Vincent, B Lang, J Newsom-Davis.   

Abstract

The Lambert-Eaton myasthenic syndrome (LEMS) is a disorder of neuromuscular transmission, often associated with small cell lung carcinoma (SCLC), and characterized by reduced quantal release of acetylcholine from the motor nerve terminals. Another neuromuscular transmission disorder, myasthenia gravis, has a well-understood autoimmunological cause. This review discusses the evidence for a similar autoimmunological effect in the development of LEMS. Injection of LEMS IgG into mice passively transfers the physiological and morphological abnormalities, which include paucity and disorganized arrangement of active zone particles believed to represent the voltage-gated calcium channels (VGCCs). Calcium influx via VGCCs into SCLC cells is reduced by LEMS IgG suggesting that in SCLC-associated LEMS, antibodies may be triggered by VGCCs expressed on these cells; this immunological cross-reactivity may lead to the neurological abnormality. Similar VGCCs on neuronally derived cells may trigger the disorder in those without a tumour. The disorder provides another example of the complicated relationships between the nervous and immune systems and tumorigenic processes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2480664     DOI: 10.1016/0166-2236(89)90109-4

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  38 in total

1.  The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen.

Authors:  C Leveque; T Hoshino; P David; Y Shoji-Kasai; K Leys; A Omori; B Lang; O el Far; K Sato; N Martin-Moutot
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

Review 2.  A central role for ROS in the functional remodelling of L-type Ca2+ channels by hypoxia.

Authors:  Chris Peers; Jason L Scragg; John P Boyle; Ian M Fearon; Shafeena C Taylor; Kim N Green; Nicola J Webster; Martin Ramsden; Hugh A Pearson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

Review 3.  Nicotinic acetylcholine receptors in health and disease.

Authors:  J Lindstrom
Journal:  Mol Neurobiol       Date:  1997-10       Impact factor: 5.590

4.  Antibody therapeutics targeting ion channels: are we there yet?

Authors:  Han Sun; Min Li
Journal:  Acta Pharmacol Sin       Date:  2013-02       Impact factor: 6.150

Review 5.  Lambert-Eaton myasthenic syndrome.

Authors:  U Seneviratne; R de Silva
Journal:  Postgrad Med J       Date:  1999-09       Impact factor: 2.401

6.  A case of Addison's disease associated with the Lambert-Eaton myasthenic syndrome.

Authors:  M Ozata; Z Odabasi; U Musabak; A Corakci; M A Gundogan
Journal:  J Endocrinol Invest       Date:  1997-06       Impact factor: 4.256

Review 7.  Lambert-Eaton myasthenic syndrome: mouse passive-transfer model illuminates disease pathology and facilitates testing therapeutic leads.

Authors:  Stephen D Meriney; Tyler B Tarr; Kristine S Ojala; Man Wu; Yizhi Li; David Lacomis; Adolfo Garcia-Ocaña; Mary Liang; Guillermo Valdomir; Peter Wipf
Journal:  Ann N Y Acad Sci       Date:  2017-11-10       Impact factor: 5.691

8.  A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization.

Authors:  Sven Jarius; Klaus P Wandinger; Sigrun Horn; Heike Heuer; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2010-03-12       Impact factor: 8.322

9.  Anti-Ca2+ channel antibody attenuates Ca2+ currents and mimics cerebellar ataxia in vivo.

Authors:  Yaping Joyce Liao; Parsa Safa; Yi-Ren Chen; Raymond A Sobel; Edward S Boyden; Richard W Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-13       Impact factor: 11.205

10.  Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients.

Authors:  G M Elrington; N M Murray; S G Spiro; J Newsom-Davis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.